Millions of people are living with diabetes worldwide, approximately 90% of whom suffer from type 2 diabetes. Despite its prevalence, many myths still persist. At Novo Nordisk, we’re committed to improving awareness and treatment for everyone at risk of diabetes across the globe.
It’s also important to manage weight, diet and exercise.
As a progressive disease, medication is often required.
Some treatments also address risk like heart disease.
8 in 10 people with type 2 diabetes face higher risk.
Insulin is just one of many types of diabetes treatments.
GLP-1 is produced in the intestine and brainstem.
You learn more from defeat than victory! Better luck next time.
Not bad at all! Still some room for improvement.
You're an expert mythbuster! Time to challenge your friends.
While blood sugar is a key part of diabetes management, there are a number of risk factors that influence your long-term health, including weight, diet, and exercise. Staying in control help reduce your risk of cardiovascular events such as heart attacks and strokes.
Type 2 diabetes is a progressive disease, meaning your condition will evolve over time. And faster if left untreated. While diet and exercise can help stabilise your condition, at some stage, diabetes will require prescribed medication to help balance your metabolism and blood sugar.
Balancing blood glucose is important as type 2 diabetes impairs the body's natural ability to produce insulin. However, treatments should also address heightened risk factors like cardiovascular disease, the leading cause of death for people with type 2 diabetes.
People living with type 2 diabetes face higher risk of cardiovascular disease, even if symptoms aren't apparent. Ask your doctor about glucose-lowering, cardio-protective treatment options.
There are several non-insulin diabetes treatments available, such as Metformin, Sulfonylureas, SGLT-2 inhibitors, and GLP-1 receptor agonists. As diabetes progresses, it may be necessary to start on one treatment or a combination of two or more.
GLP-1, or glucagon-like peptide-1, helps your body release its own insulin and is designed to respond when your blood sugar rises. It also slows down food leaving your stomach and helps reduce the amount of sugar released from your liver.